Pirenzepine blunts the nocturnal growth hormone release in insulin dependent diabetes. 1987

V Martina, and M Tagliabue, and M Maccario, and A Bertagna, and E Ghigo, and F Massara, and F Camanni
Dipartimento di Biomedicina, Università di Torino, Italy.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D010890 Pirenzepine An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients. Gastrotsepin,Gastrozepin,L-S 519,LS-519,Piren-Basan,Pirenzepin,Pirenzepin Von Ct,Pirenzepin-Ratiopharm,Pirenzepine Dihydrochloride,Pyrenzepine,Ulcoprotect,Ulgescum,Dihydrochloride, Pirenzepine,LS 519,LS519,Piren Basan,Pirenzepin Ratiopharm,Von Ct, Pirenzepin
D011976 Receptors, Muscarinic One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for MUSCARINE over NICOTINE. There are several subtypes (usually M1, M2, M3....) that are characterized by their cellular actions, pharmacology, and molecular biology. Muscarinic Acetylcholine Receptors,Muscarinic Receptors,Muscarinic Acetylcholine Receptor,Muscarinic Receptor,Acetylcholine Receptor, Muscarinic,Acetylcholine Receptors, Muscarinic,Receptor, Muscarinic,Receptor, Muscarinic Acetylcholine,Receptors, Muscarinic Acetylcholine
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013006 Growth Hormone A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized. Growth Hormone, Recombinant,Pituitary Growth Hormone,Recombinant Growth Hormone,Somatotropin,Somatotropin, Recombinant,Growth Hormone, Pituitary,Growth Hormones Pituitary, Recombinant,Pituitary Growth Hormones, Recombinant,Recombinant Growth Hormones,Recombinant Pituitary Growth Hormones,Recombinant Somatotropins,Somatotropins, Recombinant,Growth Hormones, Recombinant,Recombinant Somatotropin

Related Publications

V Martina, and M Tagliabue, and M Maccario, and A Bertagna, and E Ghigo, and F Massara, and F Camanni
December 1984, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
V Martina, and M Tagliabue, and M Maccario, and A Bertagna, and E Ghigo, and F Massara, and F Camanni
March 1987, Clinical endocrinology,
V Martina, and M Tagliabue, and M Maccario, and A Bertagna, and E Ghigo, and F Massara, and F Camanni
January 1988, Acta medica Scandinavica,
V Martina, and M Tagliabue, and M Maccario, and A Bertagna, and E Ghigo, and F Massara, and F Camanni
August 1992, The Netherlands journal of medicine,
V Martina, and M Tagliabue, and M Maccario, and A Bertagna, and E Ghigo, and F Massara, and F Camanni
April 1992, Anales espanoles de pediatria,
V Martina, and M Tagliabue, and M Maccario, and A Bertagna, and E Ghigo, and F Massara, and F Camanni
June 1977, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
V Martina, and M Tagliabue, and M Maccario, and A Bertagna, and E Ghigo, and F Massara, and F Camanni
December 1981, The Journal of clinical endocrinology and metabolism,
V Martina, and M Tagliabue, and M Maccario, and A Bertagna, and E Ghigo, and F Massara, and F Camanni
July 1996, Hormone research,
V Martina, and M Tagliabue, and M Maccario, and A Bertagna, and E Ghigo, and F Massara, and F Camanni
January 1999, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
V Martina, and M Tagliabue, and M Maccario, and A Bertagna, and E Ghigo, and F Massara, and F Camanni
February 1985, Diabetes,
Copied contents to your clipboard!